Interview part one: Chang Yi Wang, Chairperson & CEO, UBI Asia, and…
In the first of this two-part interview, the chairperson of UBI and UBI Asia explains the work that her company has done to improve the landscape for Taiwanese pharma and…
Address: 6F, No 216-5, Sec. 2, Suiyuan Road, Taichung,Taiwan
Tel: +886 4 2247 3356
For over 15 years, with headquarter in central Taiwan and a branch office in Taipei, and as the pioneer of specialty pharmaceutical distribution locally, Giddi Pharma Co., Ltd. continues to provide excellent services to its global business partners, the local medical community, as well as patients’ advocacy and support groups.
Giddi’s expertise begins with comprehensive & extensive knowledge in various business channels and all distribution models. Its unique one-stop solution, turnkey service capacity has resulted in quick market entry with great efficiency plus cost-saving advantages. From individual named patient import to full scale commercial launch; from product registration, to insurance reimbursement and formulary listing; from international cold chain logistic to pharmacovigilance, Giddi offers comprehensive coverage in each and every aspect of product commercialization.
Giddi’s achievements include several ‘Distributor Excellent Performance Awards’ from Genzyme, 5 times ‘Special Contribution for Supply, Manufacture, Research & Development of Rare Disease Medications’ from Department of Health and Presidential ‘Golden Merchant Award’.
Synergism of innovative leadership with decades of experience from core management team has repeatedly enabled Giddi to formulate adaptive strategies, overcome all challenges and accomplish ultimate goals set by our principals. Each of its 64 employees is also 100% committed to the caring, professional, integrity motto with passion and responsibility.
Giddi’s achievements and successful track records have earned solid reputation and business from global companies like Genzyme, BioMarin, Ipsen and others. With 3 sales teams each dedicated to specific sector for in depth education and relationship cultivation, Giddi is able to maintain double digits growth year after year and becomes the industry leader.
Superior functional and technical expertise coupled with extensive industry knowledge makes Giddi Pharma the ideal choice for your local business partner in Taiwan!
In the first of this two-part interview, the chairperson of UBI and UBI Asia explains the work that her company has done to improve the landscape for Taiwanese pharma and…
Calvin Tsai and Jack Wu talk about their two-pronged international approach through pharmaceuticals and nutricare. The head of the nutricare business elaborates on the challenge of introducing milk products to…
A leading figure in the Taiwanese pharmaceutical sector, Lee divulges the practicalities behind ECFA, the free trade agreement that was signed between China and Taiwan in 2010 but has not…
Charles Lin discusses the impact of investment in R&D on Lotus’s product line, and how this has shaped the competitive value of the company over the last decade, as well…
In Taiwan, GSK recently signed Memorandum of Understanding with the National Research Program of Biopharmaceuticals (NRPB), building on research partnerships in Taiwan that include a 2007 agreement with National Taiwan…
Dr. Wen, can you please explain the vision behind Mycenax, and the areas in which you are currently focused? Here at Mycenax, our vision is from bench to better life…
Dr. Karen Wen of Mycenax likened her company to a “kitchen.” Would you say the same of JHL? Racho Jordanov (RJ): We might…
The latest details regarding Article 46, a key piece of legislation attached to the second-generation health insurance reform, were announced this week. What are the key points to take away…
Phytohealth is a trailbalzer in the Taiwanese biotech industry: the first publically-listed biopharma company in the country, and the first company to receive NDA approval for a Botanical New Drug.…
In 2010, you began your last interview with us by mentioning two things: that because of the nature of this affiliate’s portfolio—with only 35% of revenues generated by pharma at…
Mr. Fang-Yue Lin was a Department of Health Minister before becoming Superintendent of TVGH just 7 short months ago. He shares with us his Insight to the reform of the…
Alex Ho has more than 15 years of significant pharmaceutical industry expertise, spanning across sales, marketing and product management in multinational companies. These companies include Novartis, Janssen, L’Oreal, GSK and…
See our Cookie Privacy Policy Here
